DFFN - Diffusion Pharmaceuticals Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Cash flows from operating activities
Net Income
-11,799
-11,799
-18,370
-1,365
-18,037
Depreciation & amortization
97.915
97.915
110.371
67.981
25.342
Deferred income taxes
332.885
332.885
-437.289
-1,056
-364.796
Stock based compensation
515.762
515.762
1,222
1,241
1,391
Change in working capital
994.442
994.442
-276.937
-2,328
1,311
Other working capital
-9,858
-9,858
-10,773
-12,780
-10,771
Other non-cash items
-
-
-
33.517
989.446
Net cash provided by operating activites
-9,858
-9,858
-10,773
-12,332
-10,768
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-
-447.823
-2.331
Other investing activites
-
-
-
-
8,501
Net cash used for investing activites
-
-
0
-447.823
8,498
Cash flows from financing activities
Debt repayment
0
0
-550
-1,880
-
Common stock issued
12,319
12,319
10,846
-
-
Other financing activites
-162.829
-162.829
-428.542
-125.98
-54.346
Net cash used privided by (used for) financing activities
16,045
16,045
9,868
20,124
1,826
Net change in cash
6,186
6,186
-905.296
7,344
-444.34
Cash at beginning of period
7,991
7,991
8,896
1,553
1,997
Cash at end of period
14,177
14,177
7,991
8,896
1,553
Free Cash Flow
Operating Cash Flow
-9,858
-9,858
-10,773
-12,332
-10,768
Capital Expenditure
-
-
-
-447.823
-2.331
Free Cash Flow
-9,858
-9,858
-10,773
-12,780
-10,771